The association between age at menarche and later risk of gestational diabetes is mediated by insulin resistance
- PMID: 29789944
- PMCID: PMC6060956
- DOI: 10.1007/s00592-018-1162-7
The association between age at menarche and later risk of gestational diabetes is mediated by insulin resistance
Abstract
Aims: Associations have been reported between age at menarche and the later risk of gestational diabetes. However, it is not known whether these associations reflect differences in insulin sensitivity and/or pancreatic β-cell function in pregnancy.
Methods: We examined this question in women enrolled in the prospective Cambridge Baby Growth Study who recalled their age at menarche in questionnaires during pregnancy. Polynomial logistic and linear regression models were used to relate menarche timing to the risk of gestational diabetes, both unadjusted and adjusted for the Homeostasis Model Assessments of insulin resistance (HOMA IR) and pancreatic β-cell function (HOMA B) at week 28 of pregnancy.
Results: Age at menarche showed a U-shaped association with gestational diabetes risk (linear term: p = 9.5 × 10-4; quadratic term: p = 1.0 × 10-3; n = 889; overall model p = 8.1 × 10-3). Age at menarche showed a negative linear association with insulin resistance (HOMA IR: β = -0.13, p = 5.2 × 10-4, n = 771), which explained the relationship between age at menarche and gestational diabetes risk (adjusted linear term going from p = 0.03-0.08; adjusted quadratic term going from p = 0.04-0.08; n = 771). Age at menarche also showed a negative linear association with β-cell function (HOMA B: β = -0.11, p = 2.8 × 10-3, n = 771) but this did not attenuate the relationship between age at menarche and gestational diabetes (adjusted linear term p = 0.02; adjusted quadratic term p = 0.03, n = 771).
Conclusions: These results suggest that the associations between age at menarche and risk of gestational diabetes and raised pregnancy glucose concentrations may be mediated by insulin resistance.
Keywords: Adiposity; Insulin sensitivity; PAPP-A; Pregnancy; Puberty.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Statement of informed consent
Informed consent was obtained from all patients for being included in the study.
Figures
References
-
- Papadimitriou A (2016) The evolution of the age at menarche from prehistorical to modern times. J Pediatr Adolesc Gynecol 29:527–530. https://www.sciencedirect.com/science/article/pii/S1083318815004295 - PubMed
-
- DiVall SA, Radovick S (2008) Pubertal development and menarche. Ann N Y Acad Sci 1135:19–28. https://onlinelibrary.wiley.com/doi/10.1196/annals.1429.026/abstract - DOI - PubMed
-
- Ahmed ML, Ong KK, Dunger DB (2009) Childhood obesity and the timing of puberty. Trends Endocrinol Metab 20:237–242. https://www.sciencedirect.com/science/article/pii/S1043276009000587 - PubMed
-
- Prentice P, Viner RM (2013) Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes (Lond) 37:1036–1043. https://www.nature.com/articles/ijo2012177 - PubMed
-
- Janghorbani M, Mansourian M, Hosseini E (2014) Systematic review and meta-analysis of age at menarche and risk of type 2 diabetes. Acta Diabetol 51:519–528. https://link.springer.com/article/10.1007%2Fs00592-014-0579-x - PubMed
MeSH terms
Substances
Grants and funding
- RG1644/Wellbeing of Women
- MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom
- QLK4-1999-01422/Fifth Framework Programme
- 07/20/Newlife Foundation for Disabled Children
- RG54608/Mothercare Charitable Foundation
- WT_/Wellcome Trust/United Kingdom
- U106179472/MRC_/Medical Research Council/United Kingdom
- 2004/03/World Cancer Research Fund
- MC_UU_00014/5/MRC_/Medical Research Council/United Kingdom
- G1001995/MRC_/Medical Research Council/United Kingdom
- MC_UU_12012/5/MRC_/Medical Research Council/United Kingdom
- MC_U106179472/MRC_/Medical Research Council/United Kingdom
- 7500001180/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
